A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias Ross PenninkilampiGuy D. Eslick Systematic Review 20 June 2018 Pages: 485 - 497
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview Floriana De AngelisDomenico PlantoneJeremy Chataway Review Article 03 July 2018 Pages: 499 - 526
Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors Grainne M. O’KaneNatasha B. Leighl Review Article 24 May 2018 Pages: 527 - 542
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis Bernard M. J. Uitdehaag Review Article Open access 20 June 2018 Pages: 543 - 558
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine Leda Marina PomesGiovanna GentilePaolo Martelletti Commentary 20 June 2018 Pages: 559 - 565
Polypharmacy Among Headache Patients: A Cross-Sectional Study Anna FerrariCarlo BaraldiCecilia Rustichelli Original Research Article Open access 11 May 2018 Pages: 567 - 578
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer’s Disease Patricia del CerroCarolina AlquézarÁngeles Martín-Requero Original Research Article 07 May 2018 Pages: 579 - 591
Prescription of Zolpidem and the Risk of Fatal Motor Vehicle Collisions: A Population-Based, Case-Crossover Study from South Korea Bo Ram YangYe-Jee KimJoongyub Lee Original Research Article 23 May 2018 Pages: 593 - 600
Correction to: Gadolinium-Based Contrast Agent-Related Toxicities Luca PasquiniAntonio NapolitanoMaria Camilla Rossi Espagnet Correction 15 May 2018 Pages: 601 - 601
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents Michael W. JannScott R. Penzak Correction 02 June 2018 Pages: 603 - 603
